NEXTGEN NANO LIMITEDActive
Key figures
NEXTGEN NANO LIMITED does not disclose its turnover in its latest accounts; the profit for the year is as stated in the accounts.
Ratios
2025Balance sheet structure
Filed accounts2020–2025
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Profit for the year | — | — | — | — | -704,913 |
| Cash at bank and in hand | — | — | — | — | 6,400 |
| Total assets | 922,463 | 723,272 | 751,848 | 894,394 | 761,881 |
| Total liabilities | — | — | — | — | — |
| Net assets / total equity | 840,150 | 610,321 | 500,055 | 814,233 | 608,847 |
| Average number of employees | 1 | 4 | 4 | 4 | 5 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Summary: NEXTGEN NANO LIMITED
Company
NEXTGEN NANO LIMITED is a private limited company registered with Companies House under company number 11033382. It was incorporated on 26 Oct 2017. Its status is active. The registered office is in London (WC2B). Its nature of business (SIC 2007) is research and experimental development on biotechnology (72110).
Accounts
The latest accounts in the database are for 2025 (period ending 31 Dec 2025); the company files small company accounts (filleted). Loss for the year was £704,913. Net assets were £608,847, down 25.2% on the previous year. Cash at bank and in hand was £6,400. The company had an average of 5 employees. Figures are available for 6 financial years (2020–2025).
Control and charges
One person with significant control is registered.
Filing deadlines
The next accounts are due by 30 Sep 2027. The next confirmation statement is due by 16 Oct 2026.